Year 2012

In Geneva, IP And The Catholic Church Are A Match Made In Heaven

With his distinctive clerical garb, Archbishop Silvano M. Tomasi stood out in a sea of coat and tie-wearing dignitaries at the recent General Assemblies of the World Intellectual Property Organization in Geneva. His presence is a glaring reminder to every stakeholder in the room that intellectual property, often associated with excessive and self-serving patent wars these days, has a place in the Catholic Church.

Standards-Setting Organisations Increasingly Make IPR A Priority

Washington, DC - Standards guide many aspects of our lives. They instruct how telephones talk to each other, how the life sciences community shares information, how electrical devices are charged, and how the internet runs, among other things.

It’s standard-setting organisations (SSOs) that facilitate discussions among stakeholders - including intellectual property owners and users - and produce common, typically voluntary technical standards to address needs and concerns of those using the technology. Companies need to make compatible or interoperable products that comply with these standards in order to compete in the global marketplace. And intellectual property is increasingly coming into play in the development of these standards.

EU Rights Owners Blast ICT Industry For Trying To “Hijack” Copyright Levy System Talks

Copyright collective management and creators' organisations Monday accused digital technology industry group DIGITALEUROPE of trying to hijack a mediation process aimed at straightening out the EU's messy system of private copying and reprographic levies. In its 4 October paper setting out alternatives to device-based copyright levies, DIGITALEUROPE urged the European Commission to initiate comprehensive reform that includes replacing levies with some other forms of compensation to rights holders.

Panellists: Global Health Justice Needs Government Commitment, New Innovation Models

Global health needs innovation but also to ensure equitable access for the world population, panellists at a roundtable said last week. At issue is the capacity of the pharmaceutical industry to innovate, and the potential barriers to access in a context of widespread diseases that blur the boundaries between developed and developing countries. Most panellists concluded that governments should hold primary responsibility for the health of their populations.